IBDEI2NU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44645,0)
 ;;=Z99.2^^200^2229^141
 ;;^UTILITY(U,$J,358.3,44645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44645,1,3,0)
 ;;=3^Renal Dialysis Dependence
 ;;^UTILITY(U,$J,358.3,44645,1,4,0)
 ;;=4^Z99.2
 ;;^UTILITY(U,$J,358.3,44645,2)
 ;;=^5063758
 ;;^UTILITY(U,$J,358.3,44646,0)
 ;;=Z99.81^^200^2229^144
 ;;^UTILITY(U,$J,358.3,44646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44646,1,3,0)
 ;;=3^Supplemental Oxygen Dependence
 ;;^UTILITY(U,$J,358.3,44646,1,4,0)
 ;;=4^Z99.81
 ;;^UTILITY(U,$J,358.3,44646,2)
 ;;=^5063760
 ;;^UTILITY(U,$J,358.3,44647,0)
 ;;=Z90.79^^200^2229^2
 ;;^UTILITY(U,$J,358.3,44647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44647,1,3,0)
 ;;=3^Acquired Absence of Genital Organs NEC
 ;;^UTILITY(U,$J,358.3,44647,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,44647,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,44648,0)
 ;;=Z90.5^^200^2229^3
 ;;^UTILITY(U,$J,358.3,44648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44648,1,3,0)
 ;;=3^Acquired Absence of Kidney
 ;;^UTILITY(U,$J,358.3,44648,1,4,0)
 ;;=4^Z90.5
 ;;^UTILITY(U,$J,358.3,44648,2)
 ;;=^5063590
 ;;^UTILITY(U,$J,358.3,44649,0)
 ;;=Z90.2^^200^2229^6
 ;;^UTILITY(U,$J,358.3,44649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44649,1,3,0)
 ;;=3^Acquired Absence of Lung (part of)
 ;;^UTILITY(U,$J,358.3,44649,1,4,0)
 ;;=4^Z90.2
 ;;^UTILITY(U,$J,358.3,44649,2)
 ;;=^5063585
 ;;^UTILITY(U,$J,358.3,44650,0)
 ;;=Z98.1^^200^2229^10
 ;;^UTILITY(U,$J,358.3,44650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44650,1,3,0)
 ;;=3^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,44650,1,4,0)
 ;;=4^Z98.1
 ;;^UTILITY(U,$J,358.3,44650,2)
 ;;=^5063734
 ;;^UTILITY(U,$J,358.3,44651,0)
 ;;=Z94.7^^200^2229^16
 ;;^UTILITY(U,$J,358.3,44651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44651,1,3,0)
 ;;=3^Corneal Transplant Status
 ;;^UTILITY(U,$J,358.3,44651,1,4,0)
 ;;=4^Z94.7
 ;;^UTILITY(U,$J,358.3,44651,2)
 ;;=^5063661
 ;;^UTILITY(U,$J,358.3,44652,0)
 ;;=Z83.511^^200^2229^30
 ;;^UTILITY(U,$J,358.3,44652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44652,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,44652,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,44652,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,44653,0)
 ;;=Z80.52^^200^2229^33
 ;;^UTILITY(U,$J,358.3,44653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44653,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,44653,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,44653,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,44654,0)
 ;;=Z80.51^^200^2229^36
 ;;^UTILITY(U,$J,358.3,44654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44654,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,44654,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,44654,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,44655,0)
 ;;=Z83.41^^200^2229^43
 ;;^UTILITY(U,$J,358.3,44655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44655,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,44655,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,44655,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,44656,0)
 ;;=Z81.8^^200^2229^50
 ;;^UTILITY(U,$J,358.3,44656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44656,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,44656,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,44656,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,44657,0)
 ;;=Z81.4^^200^2229^51
 ;;^UTILITY(U,$J,358.3,44657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44657,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,44657,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,44657,2)
 ;;=^5063362
